Topline Results for Darigabat in Phase 1 Acute Anxiety Clinical Trial
Feb 15, 2022 at 8:00 AM EST
Supporting Materials
Cerevel is now part of AbbVie
Together we will deliver science that takes us closer to meaningful change for people with neurological and psychiatric disorders.